All eight stages of a stimulation protocol that used one then two extrastimuli from the right ventricular apex in sinus rhythm and three ventricular drive rates (100, 120, and 140 
Programmed ventricular stimulation is performed in patients with recurrent sustained ventricular tachycardia either as part of serial drug studies to identify suppressive treatment or to localise the origin by activation map- ping."q Most protocols are performed as a fixed series of steps in the belief that each successive stage both adds to the overall sensitivity and individually is more likely to induce tachycardia than the previous step. Although different stimulation protocols have been assessed as a whole for their ability to initiate tachycardia, the relative likelihood that individual stages of the protocol will induce ventricular tachycardia has not been evaluated. Consequently, it is not known whether the steps in a stimulation protocol are, individually, increasingly likely to induce tachycardia or are a random sequence of equally effective steps.56 To evaluate the relative sensitivity and specificity of individual steps within a stimulation protocol, we performed all eight stages, irrespective of whether sustained ventricular tachycardia was induced at any stage.
Patients and methods
The study was performed prospectively in consecutive patients undergoing programmed ventricular stimulation as a baseline for serial drug testing to design appropriate treatment. Patients gave their written informed consent before they entered the study. All antiarrhythmic drugs (except amiodarone) were stopped for at least five half lives before the study. The patient was starved for at least four hours before the study and no premedication was given. All patients had previously undergone cardiac catheterisation to exclude critical coronary artery disease.
Patients were included if the induced ventricular tachycardia was 11   57  M  IHD  S  S  S  S  S  12  57  M  IHD  S  S  S  S  S  13  58  F  IHD  S  S   14  49  M  IHD  S  S  S  15  62  M  IHD  S  S  16  57  M  IHD  NS  S  17  64  M  IHD  S  18  64  M  IHD  NS  S  19  67  M  IHD  S  S  S  S  S  S  20  77  F  IHD  S  21  57  M  IHD  S  S  S  S  22  47  M  NH  S  S  23  68  M  IHD  S  24  51  M  IHD  S  S  S IHD, ischaemic heart disease; NH, normal heart, NS, non-sustained ventricular tachycardia; S, sustained ventricular tachycardia. Ll__L effective than stage two. Our data also showed 140 that two extrastimuli were more likely to te initiate ventricular tachycardia than was a single extrastimulus. Where both non-sustained and sustained ventricular tachycardia were induced in an individual, the sustained ventricular tachycardia was always induced when a faster ventricular drive rate was used. On the basis of these results it would be logical to rearrange the order to produce a graded protocol. The initial steps would be a single extrastimulus in sinus rhythm and after drive rates of increasing rate, followed by double extrastimuli. This would represent a more truly progressive protocol than the original protocol because two extrastimuli after a drive rate of 100 beats/min were a more vigorous test than one extrastimulus after a drive rate of 140 beats/min. The drive rate of 120 beats/min could be omitted because this was not significantly different from 100 or 140 beats/min (supported by the study by Borggrefe et 
alP).
This study showed that the two stages, one or two extrastimuli with a ventricular drive of 140 beats/min, were nearly as sensitive (95 %) as the eight stage protocol in our group of patients. Therefore, it seems logical to perform only these two stages if inducibility of tachycardia was the only end point (that is, for activation mapping).
The patient population was not prospectively selected but was obviously biased by referral by other centres of patients with drug resistant, sustained ventricular tachycardia. This patient group closely reflects that seen in our clinical practice. Most This study examined the relative (not absolute) sensitivity and specificity of the individual steps within this protocol, which were close to the consensus,'5 and did not explore other controversies in programmed stimulation. The use of multiple sites in the right and left ventricle is probably not practical in serial drug studies. In screening procedures the use of a third extrastimulus or a faster drive rate were shown to be as sensitive as using the right ventricular outflow tract6"2 16 or left ventricular pacing sites.'7 Increasing the strength of the current to decrease the refractory period does not seem to increase sensitivity but may decrease specificity.61 18 Different stages of the protocol did not induce different configurations of ventricular tachycardia. This was probably a direct result of limiting the number of extrastimuli to two in patients with systained ventricular tachycardia. This suggests that if a non-clinical ventricular tachycardia is induced initially, increasing the ventricular drive rate or number of extrastimuli (up to a maximum of two) is unlikely to induce the clinical tachycardia; two patients in this trial had only non-clinical tachycardia induced. Ventricular fibrillation or haemodynamically unstable ventricular tachycardia were not induced at a later stage if stable ventricular tachycardia had been induced initially in any patient. This suggests that while the later stages of this protocol were more likely to induce ventricular tachycardia, they were not more likely to induce ventricular fibrillation or a very rapid ventricular tachycardia. The rate of ventricular tachycardia induced at a later stage was not significantly faster than the tachycardia induced at an earlier stage. Thus if only a ventricular drive rate of 140 beats/min and one or two ventricular extrasystoles were used to induce ventricular tachycardia for mapping or screening purposes it would be no more likely to provoke a faster or more unstable tachycardia than would result from running through the full protocol.
This study and earlier reports support the concept that an increase in the number of extrastimuli and an increase in the drive rate independently increase the likelihood of the induction of ventricular tachycardia. We recommend that when programmed electrical stimulation is used to assess drug treatment a single extrastimulus should be introduced during sinus rhythm and then after two ventricular drive rates at 100 beats/min and 140 beats/min. Double extrastimuli should then be introduced during sinus rhythm and after this the two ventricular drive rates may be added, producing a six stage protocol. Ifthe aim ofthe study is only to induce tachycardia (for mapping) then the protocol should start with one and two extrastimuli after a ventricular drive at 140 beats/min. This study suggests that this two stage protocol has nearly the same sensitivity (in the population studied) as the full eight
